Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Capital Expenditures: 2017-2024

Historic Capital Expenditures for Cogent Biosciences (COGT) over the last 7 years, with Dec 2024 value amounting to $573,000.

  • Cogent Biosciences' Capital Expenditures was N/A to $433,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $573,000 for FY2024, which is 79.51% down from last year.
  • Cogent Biosciences' Capital Expenditures amounted to $573,000 in FY2024, which was down 79.51% from $2.8 million recorded in FY2023.
  • Cogent Biosciences' Capital Expenditures' 5-year high stood at $6.9 million during FY2022, with a 5-year trough of $573,000 in FY2024.
  • Its 3-year average for Capital Expenditures is $3.4 million, with a median of $2.8 million in 2023.
  • Per our database at Business Quant, Cogent Biosciences' Capital Expenditures skyrocketed by 299.24% in 2022 and then tumbled by 79.51% in 2024.
  • Cogent Biosciences' Capital Expenditures (Yearly) stood at $1.7 million in 2021, then skyrocketed by 299.24% to $6.9 million in 2022, then plummeted by 59.26% to $2.8 million in 2023, then plummeted by 79.51% to $573,000 in 2024.